%PDF-1.4
%
158 0 obj
<>
endobj
202 0 obj
<>stream
application/pdf
Xavier Didelot
Quantifying the fitness benefit and cost of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy
2017-03-28T08:36:09Z
Preview
2024-03-28T18:55:17-07:00
2024-03-28T18:55:17-07:00
Mac OS X 10.12.3 Quartz PDFContext
uuid:2b5aae7d-1dd2-11b2-0a00-b60927edca00
uuid:2b5aae80-1dd2-11b2-0a00-380000000000
endstream
endobj
5 0 obj
<>
endobj
2 0 obj
<>
endobj
17 0 obj
<>
endobj
18 0 obj
<>
endobj
19 0 obj
<>
endobj
123 0 obj
<>/ProcSet[/PDF/Text]>>/Type/Page>>
endobj
126 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
127 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
128 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
129 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
130 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
131 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
216 0 obj
[218 0 R 219 0 R]
endobj
217 0 obj
<>stream
HdQn0?b6*%!m! (``$b!
EI^.%&+*.4CJ]pK0|c<NWJ"Snjx͞%{/\$-ZrhxE/Cg+Pa3RZ uV//_ȸmLt~`k08%/dVUW9כ06̸,yr
>!--A=:{